ACAD
35.59
-0.97
-2.65%
AEMD
0.196
-0.01
-4.6341%
APRI
1.54
-0.13
-7.78%
ARNA
4.24
-0.07
-1.62%
ATEC
1.31
-0.03
-2.24%
CNAT
5.94
-0.16
-2.6246%
CRXM
0.479
-0.017
-3.3333%
CYTX
0.71
-0.191
-21.1667%
DXCM
66.13
-2.06
-3.02%
GNMK
9.78
-0.41
-4.02%
HALO
15.225
-0.465
-2.964%
ILMN
185.56
-4.09
-2.16%
INNV
0.153
0.00
0.00%
INO
8.21
-0.25
-2.96%
ISCO
0.054
-0.005
-9.244%
ISIS
58.47
-1.19
-1.99%
LGND
77.2
-2.65
-3.32%
LPTN
2.079
+0.079
+3.950%
MBVX
2.91
+0.03
+1.04%
MEIP
2.01
-0.12
-5.63%
MNOV
3.86
-0.08
-2.03%
MRTX
27.6
-0.68
-2.40%
MSTX
0.515
-0.013
-2.3886%
NBIX
35.74
-0.34
-0.94%
NUVA
46.5
+0.84
+1.84%
ONCS
0.266
+0.001
+0.377%
ONVO
4.88
+0.08
+1.67%
OREX
6.52
-0.2
-2.98%
OTIC
27.35
-1.96
-6.69%
QDEL
22.77
-0.31
-1.34%
RCPT
147.55
-5.9
-3.84%
RGLS
12.73
-0.72
-5.35%
RMD
64.51
-1.14
-1.74%
SCIE
0.022
0.00
0.00%
SPHS
0.702
-0.049
-6.4667%
SRNE
10.2
-0.52
-4.85%
TROV
8.28
-0.62
-6.97%
VICL
0.91
-0.01
-1.09%
VOLC
17.99
0.00
0.00%
ZGNX
1.405
-0.075
-5.068%
ACAD
35.59
-0.97
-2.65%
AEMD
0.196
-0.01
-4.6341%
APRI
1.54
-0.13
-7.78%
ARNA
4.24
-0.07
-1.62%
ATEC
1.31
-0.03
-2.24%
CNAT
5.94
-0.16
-2.6246%
CRXM
0.479
-0.017
-3.3333%
CYTX
0.71
-0.191
-21.1667%
DXCM
66.13
-2.06
-3.02%
GNMK
9.78
-0.41
-4.02%
HALO
15.225
-0.465
-2.964%
ILMN
185.56
-4.09
-2.16%
INNV
0.153
0.00
0.00%
INO
8.21
-0.25
-2.96%
ISCO
0.054
-0.005
-9.244%
ISIS
58.47
-1.19
-1.99%
LGND
77.2
-2.65
-3.32%
LPTN
2.079
+0.079
+3.950%
MBVX
2.91
+0.03
+1.04%
MEIP
2.01
-0.12
-5.63%
MNOV
3.86
-0.08
-2.03%
MRTX
27.6
-0.68
-2.40%
MSTX
0.515
-0.013
-2.3886%
NBIX
35.74
-0.34
-0.94%
NUVA
46.5
+0.84
+1.84%
ONCS
0.266
+0.001
+0.377%
ONVO
4.88
+0.08
+1.67%
OREX
6.52
-0.2
-2.98%
OTIC
27.35
-1.96
-6.69%
QDEL
22.77
-0.31
-1.34%
RCPT
147.55
-5.9
-3.84%
RGLS
12.73
-0.72
-5.35%
RMD
64.51
-1.14
-1.74%
SCIE
0.022
0.00
0.00%
SPHS
0.702
-0.049
-6.4667%
SRNE
10.2
-0.52
-4.85%
TROV
8.28
-0.62
-6.97%
VICL
0.91
-0.01
-1.09%
VOLC
17.99
0.00
0.00%
ZGNX
1.405
-0.075
-5.068%
Home » Archive by Category

NYSE:PFE

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

October 5, 2011 – 5:31 am

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…